Genertec Universal Medical reports strong H1 profit and revenue growth

Genertec Universal Medical Group reported revenue of RMB7,580.7 million for the six months ended June 30, 2025, a 15.9% increase from RMB6,542.7 million in the prior year. Profit for the period rose by 6.6% to RMB1,335.2 million, with profit attributable to owners of the parent reaching RMB1,228.1 million, an 8.0% increase. Basic earnings per share were RMB0.65, up from RMB0.60.

The healthcare business was a key driver, with revenue increasing by 27.7% to RMB4,963.8 million, contributing 65.5% to total revenue. The finance business also grew, with revenue up 6.9% to RMB2,851.3 million. Total assets decreased slightly by 0.4% to RMB85,716.6 million, while equity attributable to owners of the parent increased by 3.1% to RMB17,703.4 million.

The Group maintained healthy profitability indicators, with return on total assets at 3.11% and return on equity at 14.08%. The net interest margin was 4.34%, and the net interest spread was 3.82%, showing improvements over the previous year.